MAP2K7 and melanoma: The available melanoma treatments range from conventional excisional surgery and chemotherapy to targeted systemic immunotherapy treatments or the combination of treatments (BRAF inhibitor, MEK inhibitor, anti-PD-1 monoclonal antibody, and anti-CTLA-4 monoclonal antibody) [7,8].